Skip to content

About / Media Center

Trinity Press Releases

Filter by Type:
February 28, 2018

What Rare Disease Day Means to Trinity

Rare Disease Day falls on Wednesday, February 28th. At Trinity, we work closely with many life sciences companies developing treatments for rare disease patients. Research is crucial to the rare community, and we are committed to help raise awareness around the...
Read the Press Release
January 24, 2018

New Report from Trinity Highlights Key Barriers to U.S. Biosimilar Adoption

Complex Pricing Structures, Legal and Regulatory Barriers, and Clinical Uncertainty Hinder Progress in Biosimilar Market Access Key findings from the report, which seeks to reveal opportunities to accelerate biosimilar adoption, include the following: Biosimilar pricing to date has not offered the...
Read the Press Release
January 22, 2018

Trinity’s John Greenway and Nick Simmons-Stern to Present Case Study at CBI’s Biosimilar Summit

John Greenaway, Jillian Scaife, Nick Simmons-Stern, Ali Haber, and Christina Danosi are traveling to Alexandria, Virginia this week to attend CBI’s Biosimilars Summit. At the conference, they’ll discuss how to overcome reimbursement hurdles in an expanding U.S. biosimilars market. Learn more about...
Read the Press Release
January 5, 2018

Senior Partner Leslie Sandberg Orne Discusses Top Drugs for 2018

In a recent article for Formulary Watch, editor Christine Blank spoke with Trinity’s Leslie Sandberg Orne about new blockbuster drugs to hit the marketplace in 2018 that will treat HIV, diabetes, cancer, migraine headaches and other conditions. Check out Leslie’s insights...
Read the Press Release
Back To Top